Showing 1,041 - 1,060 results of 34,158 for search '"Hepatitis"', query time: 0.22s Refine Results
  1. 1041

    TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma by Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin

    Published 2020-01-01
    “…<i>AFP</i> mRNA levels showed strong positive correlations with TUG1 and unfavorable prognosis in patients with non-hepatitis B/non-hepatitis C HCC (NBNC-HCC). T<sub>3</sub>/TR, TUG1, and AFP may potentially serve as effective prognostic markers for NBNC-HCC.…”
    Get full text
    Article
  2. 1042
  3. 1043
  4. 1044
  5. 1045
  6. 1046
  7. 1047
  8. 1048
  9. 1049
  10. 1050
  11. 1051
  12. 1052
  13. 1053

    Hepatitis C Virus Reactivation in Anti-HCV Antibody-Positive Patients with Chronic Hepatitis B Following Anti-HBV Therapies by Yi-Tse Su, Ming-Ling Chang, Rong-Nan Chien, Yun-Fan Liaw

    Published 2022-08-01
    “…Background and Aims: Whether hepatitis C virus (HCV) reactivation occurs and how the viral load evolves in anti-HCV antibody-positive chronic hepatitis B (CHB) patients who underwent nucleos(t)ide analogue (Nuc) therapies remain unsolved. …”
    Get full text
    Article
  14. 1054

    Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment by Lisa Sandmann, Birgit Bremer, Valerie Ohlendorf, Jerzy Jaroszewicz, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy

    Published 2024-02-01
    “…Background: The hepatitis B core-related antigen (HBcrAg) correlates with HBV DNA in patients with chronic HBV infection without antiviral treatment. …”
    Get full text
    Article
  15. 1055

    Tg1.4HBV-s-rec mice, a crossbred hepatitis B virus-transgenic model, develop mild hepatitis by Stefan Schefczyk, Xufeng Luo, Yaojie Liang, Mike Hasenberg, Bernd Walkenfort, Martin Trippler, Jonas Schuhenn, Kathrin Sutter, Mengji Lu, Heiner Wedemeyer, Hartmut H. Schmidt, Ruth Broering

    Published 2023-12-01
    “…Abstract Hepatitis B virus (HBV)-transgenic mice exhibit competent innate immunity and are therefore an ideal model for considering intrinsic or cell-based mechanisms in HBV pathophysiology. …”
    Get full text
    Article
  16. 1056
  17. 1057
  18. 1058

    Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus by Stephan Menne, Steffen Wildum, Guido Steiner, Manasa Suresh, Kyle Korolowicz, Maria Balarezo, Changsuek Yon, Marta Murreddu, Xupeng Hong, Bhaskar V. Kallakury, Robin Tucker, Song Yang, John A.T. Young, Hassan Javanbakht

    Published 2020-06-01
    “…RG7834 is a small‐molecule inhibitor of hepatitis B virus (HBV) gene expression that significantly reduces the levels of hepatitis B surface antigen (HBsAg) and HBV DNA in a humanized liver HBV mouse model. …”
    Get full text
    Article
  19. 1059
  20. 1060